5Bianchi L, Campione E, Marulli GC, et al .Actinic keratosis treated with an immune response modifier: a case report of six patients[J]. Clin Exp Dermatol, 2003, 28 (Suppl 1) :39.
6Korman N, Moy R, Ling M, et al. Dosing with 5% Imiquimod cream 3 times per week for the treatment of actinic keratosisresults of two phase 3, randomized, double- blind, parallel group, vehicle - controlled trials[J ]. Arch Dermatol,2005,141( 4) :467.
7Lysa B, Tartler U, Wolf R, et al .Gene expression in actinic keratoses: pharmacological modulation by imiquimod [J]. Br J Dermatol, 2004,151(6) : 1 150.
8Vidal D, Matias- Guiu X, Alomar A.Efficacy of imiquimod for the expression of Bcl - 2, Ki67, p53 and basal cell carcinoma apoptosis[J] . British Journal of Dermatology, 2004,15(3) : 656.
9Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell careinoma[J]. J Am Acad Dermatol, 2004, 50(5) : 722.
7Vilata J J, Badia X. ESCCRIM group. Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts[J]. Int J STD AIDS, 2003, 14(1): 11-17.
8Eklind J, Tartler U, Maschke J, et al. Imiquimod to treat different cancers of the epidermis[J]. Dermatol Surg, 2003, 29(8):890-896.
9Kende M, Lupton HW, Canonico PG. Treatment of experimental viral infections with immunomodulators [J]. Adv Biosciences,1988, 68(1): 51-63.
10Kono T, Kondo S, Pastore S, et al. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression[J]. Lymphokine Cytokine Res, 1994, 13(2): 71-76.
7Pirotta M, Stein AN, Conway EL, et al. Genital warts in- cidence and healthcare resource utilisation in Australia[J]. Sex Transim Infect, 2010,86(3) : 181.
8Koshiol JE, Laurent SA, Pimenta JM. Rate and predicto- rs of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States[J]. Sex Transm Dis, 2004,31 (12) : 748.
9Parkin DM, Louie KS, Clifford G.Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region[J]. Vaccine, 2008, 26 (12):1.
10O' Mahony C.Genital warts:current and future managem- ent options[J]. Am J Clin Dermatol, 2005,6 (4) : 239.
